/주식/OPGN
OPGN

OPGN

USD

OpGen Inc. Common Stock

$4.890+0.120 (2.516%)

실시간 가격

Healthcare
의료 기기
미국

가격 차트

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$4.770

고가

$4.950

저가

$4.515

거래량

0.00M

기업 기본 정보

시가총액

50.3M

산업

의료 기기

국가

United States

거래 통계

평균 거래량

0.01M

거래소

PNK

통화

USD

52주 범위

저가 $0.527현재가 $4.890고가 $5.39

AI 분석 리포트

마지막 업데이트: 2025년 4월 17일
AI 생성데이터 소스: Yahoo Finance, Bloomberg, SEC

[OPGN: OpGen Inc. Common Stock]: Is This Biotech Stock Showing Signs of Life?

Stock Symbol: OPGN Generate Date: 2025-04-17 11:50:13

Alright, let's take a look at OpGen (OPGN). This is a company in the medical devices world, specifically focused on fighting infectious diseases. Think of them as trying to develop better tools to quickly figure out and treat nasty bugs. The stock itself? Well, it's been a bit of a rollercoaster lately, and maybe showing some interesting moves.

Recent News Buzz (Inferred)

We don't have specific news headlines here, but the overall picture is leaning towards positive. Why? Because the AI analysis we've got is pretty upbeat. It's highlighting "Bullish Momentum" and calling OPGN an "Undervalued Gem." That's generally a good vibe. The AI seems to think things are looking up technically, and that the stock might be cheap compared to what it could be worth. So, even without news headlines screaming good things, the data suggests a shift towards a more positive outlook.

Price Check: From Slumber to Spiking?

Looking at the price history over the last month or so, it's been a real mixed bag. If you go back to January and February, the stock was mostly drifting downwards, hitting lows below a dollar. There were days with almost no trading activity – basically flatlining. Then, around mid-March, things started to get interesting.

Suddenly, we see a jump. The price started climbing, and not just a little bit. It went from under $1 to over $4 in a relatively short time. That's a significant move. More recently, in April, it's been bouncing around in the $3 to $4 range. It's definitely more volatile now than it was a couple of months ago.

Right now, the stock is around $4.09 (previous close $3.75). The AI prediction data seems to back up this upward trend. It points to technical indicators like the price being above its 20-day moving average, positive momentum signals, and a surge in trading volume. That volume jump is key – it suggests more people are buying in, and with conviction.

Outlook & Ideas: Potential Upside, But Tread Carefully

So, what does this all mean? It looks like OPGN might be trying to break out of a long slump. The AI is definitely seeing bullish signals, and the recent price action supports that. Could this be a chance to buy? Potentially, yes, but with a good dose of caution.

Near-Term Leaning: The data leans towards a potential 'buy' or 'accumulate' scenario for short-term traders. The bullish momentum is hard to ignore.

Potential Entry Consideration: The AI suggests entry points around $3.62 to $4.03. Given the current price is around $4.09, waiting for a slight dip back towards the $4.00 level, or even the $3.90s, might be a strategy for someone looking to get in. This area has seen some recent support, and it aligns with the AI's entry range.

Potential Exit/Stop-Loss Consideration: Risk management is crucial, especially with volatile stocks like this. The AI recommends a stop-loss around $3.439. This makes sense as it's below recent lows and would help protect against a sudden reversal. For taking profits, the AI points to a target of $5.48. That's a decent potential gain if the bullish trend continues. However, remember these are just potential levels.

Important Caveats: OPGN is still considered a risky stock. The AI itself flags "Extreme Volatility," "Low Market Correlation," and "Small Market Cap" as risk factors. This isn't a stock for the faint of heart or for long-term, conservative investors. The AI even labels it suitable for "Aggressive" and "Value" investors, with a "Short-term Trading" horizon (1-2 weeks). Also, while the AI highlights positive technicals and value, it also notes some fundamental weaknesses like a negative Return on Equity and high debt. These are things to keep in mind.

Company Context - What Do They Actually Do?

Just a quick reminder: OpGen is in the medical device industry, focusing on infectious diseases. This sector can be sensitive to news about outbreaks, new treatments, and healthcare spending. Keep an eye on developments in this area, as they could impact OPGN's stock.

In a Nutshell: OPGN is showing signs of a potential turnaround, with bullish technical indicators and a recent price spike. Short-term traders might see an opportunity, but it's crucial to be aware of the risks, manage your positions carefully with stop-losses, and do your own thorough research before making any decisions. This is a volatile stock, so buckle up if you decide to take a closer look.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. The stock market is inherently risky, and past performance is not indicative of future results. Investors should conduct their own independent research and/or consult with a qualified financial advisor before making any investment decisions.

AI 예측Beta

AI 추천

중립

업데이트 시간: 2025년 4월 28일 오후 05:51

약세중립강세

58.3% 신뢰도

리스크 & 트레이딩

리스크 수준3/5
중위험
적합 대상
공격적가치
트레이딩 가이드

진입점

$4.43

익절

$6.72

손절

$4.29

핵심 요소

PDI 38.5이(가) ADX 9.1과 함께 MDI 37.2 위에 있어 강세 추세를 시사합니다.
MACD -0.0024이(가) 신호선 0.0081 아래에 있어 약세 교차를 나타냅니다.

최신 정보 받기

가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기